Aperam SA
OTC:APEMY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aperam SA
OTC:APEMY
|
LU |
|
DRDGOLD Ltd
NYSE:DRD
|
ZA |
|
PLC SpA
MIL:PLC
|
IT |
|
I
|
ITV PLC
OTC:ITVPY
|
UK |
|
Delta Djakarta Tbk PT
IDX:DLTA
|
ID |
|
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
|
IL |
|
Haulotte Group SA
PAR:PIG
|
FR |
|
IDFC Ltd
NSE:IDFC
|
IN |
|
D
|
Dream Us Co
KOSDAQ:060570
|
KR |
Wall Street
Price Targets
APEMY Price Targets Summary
Aperam SA
According to Wall Street analysts, the average 1-year price target for
APEMY
is 49.54 USD
with a low forecast of 36.02 USD and a high forecast of 77.39 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is APEMY's stock price target?
Price Target
49.54
USD
According to Wall Street analysts, the average 1-year price target for
APEMY
is 49.54 USD
with a low forecast of 36.02 USD and a high forecast of 77.39 USD.
What is Aperam SA's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Aperam SA's revenue is
2%.
The projected
CAGR
for the next 4 years is
6%.
What is Aperam SA's Operating Income forecast?
Projected CAGR
41%
For the last 13 years the
compound annual growth rate for
Aperam SA's operating income is
11%.
The projected
CAGR
for the next 4 years is
41%.
What is Aperam SA's Net Income forecast?
Projected CAGR
14%
The
compound annual growth rate
of Aperam SA's net income for the next 4 years is
14%.
